Inhibition of IDO Activity Increases Arthritis Severity in Mice
Author Information
Author(s): Szántó Sándor, Koreny Tamás, Mikecz Katalin, Glant Tibor T, Szekanecz Zoltán, Varga John
Primary Institution: Rush University Medical Center
Hypothesis
Does inhibition of indoleamine 2,3-dioxygenase (IDO) affect the severity of collagen-induced arthritis in mice?
Conclusion
Inhibiting IDO activity worsens the severity and incidence of collagen-induced arthritis in mice.
Supporting Evidence
- IDO activity was increased in the acute phase of arthritis.
- Mice treated with 1-MT showed a higher incidence of arthritis.
- Histological analysis confirmed typical arthritis features in 1-MT treated mice.
- 1-MT treatment resulted in enhanced immune responses.
- Blocking IDO activity led to a more dominant Th1 immune response.
Takeaway
When scientists blocked a protein that helps control inflammation, mice got sicker from arthritis. This shows that the protein is important for keeping the disease in check.
Methodology
Mice were treated with 1-methyl-tryptophan (1-MT) to inhibit IDO and monitored for arthritis development and immune responses.
Limitations
The study was conducted in a mouse model, which may not fully replicate human rheumatoid arthritis.
Participant Demographics
DBA/1 male mice, 6 to 8 weeks of age.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website